OVID
Ovid Therapeutics Inc
Halal Rating :
Last Price
$0.74
Last updated:
Market Cap
-
7D Change
-8.11%
1 Year Change
-77.54%
Company Overview
Industries
Exchange
Next Earnings Date
Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing medicines for patients with rare neurological disorders. The company specializes in developing treatments for conditions affecting the central nervous system (CNS). Their pipeline includes potential treatments for epileptic encephalopathies, Angelman syndrome, and other neurological conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $173000.0 | $13.4m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $169000.0 | $20.69m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $148000.0 | $17.57m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Ovid Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.